CNTF and retinitis pigmentosa 1: Last, with the comparable therapeutic effect of OSM-NP and CNTF-NP in the RP rat model, this work offers a mutation-independent treatment strategy to benefit a diverse range of patients with RP and other retinal degenerative diseases, potentially including age-related macular degeneration and glaucoma.